Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neurofibromatosis 1 × mirdametinib × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1

Interventions

AZD 6244 7 trametinib 4 omipalisib 1 mirdametinib 1 dabrafenib 1 Vincristine 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Inhalation 1 Dosage Forms 1 Curcumin 1 Control Groups 1 Carboplatin 1 Biopsy 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03962543 2025-08-07

ReNeu

SpringWorks Therapeutics, Inc.

Phase 2 Active not recruiting

114 enrolled 25 charts 1 FDA

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡